Skip to content
Agentic OS
Menu

Intelligence / B2B SaaS / Acquisitions / Vireo Growth Inc.

M&Acompleted an acquisition (SEC 8-K)26 Aug 2026

Vireo Growth Inc.

26 Aug 2026: Completed an acquisition (SEC 8-K) · Pharma and biotech. Recorded in the SEC EDGAR full-text search.

View the source record

Filed
26 Aug 2026
Ticker
VREOF
Role
Completed an acquisition
Sector
Pharma and biotech
Sic
2834
Items
2.01, 3.02, 7.01, 9.01
Summary
On August 21, 2026, Vireo Growth Inc. ("Vireo" or the "Company"), completed the previously announced acquisition of all of the issued and outstanding common shares (the "C21 Shares") of C21 Investments Inc. ("C21"), pursuant to the arrangement agreement dated June 14, 2026, by and between Vireo and C21 (the "Arrangemen
Location
Minneapolis, MN
State
Minnesota
Country
United States
SEC CIK
1771706
Reference
0001104659-26-101481
What this signal means

Integration means consolidating tools and vendors: the buyer re-platforms the target, and an acquired company's stack is reviewed by its new owner.

  1. Completed an acquisition leads with 189 of 292, then Sold assets or a business (82).
  2. 103 added in the 30 days to 19 Nov 2026.
Reach them with AOS

Find the decision makers at Vireo Growth Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this m&a signal, for your approval.

Start free

Across AOS Research

Other records for Vireo Growth Inc. in our registers.

More in Completed an acquisition

Acquisitions

See all

Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 2.01 (completion of an acquisition or disposition of assets) filed with the SEC in the last 90 days. The role (buyer, company acquired, seller) is read from the filing's own wording, which is quoted on each row. AOS shows what the public record says; it does not verify or endorse the company.